195 related articles for article (PubMed ID: 32532578)
1. Diagnostic performance of imaging techniques for detecting of local recurrence after prostate brachytherapy.
Karahissarlian V; Sargos P; Blais E; Cazeau AL; Fontes F; Petitpierre F; Rigou G; De Vaugelade C; Mariey A; Hindié E; Thomas L
Cancer Radiother; 2020 Jul; 24(4):323-331. PubMed ID: 32532578
[TBL] [Abstract][Full Text] [Related]
2.
Kanoun S; Walker P; Vrigneaud JM; Depardon E; Barbier V; Humbert O; Moulin M; Créhange G; Cormier L; Loffroy R; Brunotte F; Cochet A
Int J Radiat Oncol Biol Phys; 2017 Apr; 97(5):986-994. PubMed ID: 28333020
[TBL] [Abstract][Full Text] [Related]
3. 18F-Choline PET/CT and Prostate MRI for Staging Patients With Biochemical Relapse After Irradiation for Prostate Cancer.
Quero L; Vercellino L; de Kerviler E; Mongiat-Artus P; Culine S; Merlet P; Ravery V; Meria P; Desgrandchamps F; Hennequin C
Clin Nucl Med; 2015 Nov; 40(11):e492-5. PubMed ID: 26252326
[TBL] [Abstract][Full Text] [Related]
4. Localization of radio-recurrence within the prostate: anti-3-18F-FACBC PET/CT compared with multiparametric MRI using histopathology as reference standard.
Tulipan AJ; Hole KH; Vlatkovic L; Revheim ME; Reijnen JS; Willoch F; Seierstad T; Lilleby W
Acta Radiol; 2019 Aug; 60(8):1028-1038. PubMed ID: 30379559
[No Abstract] [Full Text] [Related]
5. Role of PET-CT with
Puche-Sanz I; Triviño-Ibáñez E; Vázquez-Alonso F; Llamas-Elvira JM; Cózar-Olmo JM; Rodríguez-Fernández A
Actas Urol Esp; 2017 Sep; 41(7):437-444. PubMed ID: 28389027
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of
López Rodríguez E; Tirado Hospital JL; Álvarez Pérez RM; Gómez Izquierdo L; Jiménez-Hoyuela JM
Actas Urol Esp (Engl Ed); 2020; 44(6):437-443. PubMed ID: 32576406
[TBL] [Abstract][Full Text] [Related]
7. [PET/CT and biochemical recurrence of prostate adenocarcinoma: Added value of
Gauthé M; Belissant O; Girard A; Zhang Yin J; Ohnona J; Cottereau AS; Nataf V; Balogova S; Pontvert D; Lebret T; Guillonneau B; Cussenot O; Talbot JN
Prog Urol; 2017; 27(8-9):474-481. PubMed ID: 28576423
[TBL] [Abstract][Full Text] [Related]
8. 18F-Fluorocholine PET/CT Complementing the Role of Dynamic Contrast-Enhanced MRI for Providing Comprehensive Diagnostic Workup in Prostate Cancer Patients With Suspected Relapse Following Radical Prostatectomy.
Vadi SK; Singh B; Basher RK; Watts A; Sood AK; Lal A; Kakkar N; Singh SK
Clin Nucl Med; 2017 Aug; 42(8):e355-e361. PubMed ID: 28525448
[TBL] [Abstract][Full Text] [Related]
9. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
10. [Biochemical recurrence after curative treatment for localized prostate cancer: Performance of choline PET/CT in the assessment of local recurrence].
Poncet D; Arnoux V; Descotes JL; Rambeaud JJ; Verry C; Terrier N; Boillot B; Dubreuil J; Lanchon C; Carnicelli D; Fiard G; Long JA
Prog Urol; 2015 May; 25(6):325-30. PubMed ID: 25748788
[TBL] [Abstract][Full Text] [Related]
11. Comparison between MRI and choline-PET trans-perineal target biopsies and saturation biopsies for detection and topography of intra-prostatic recurrence after primary radiation therapy for prostate cancer.
Biscans C; Vallée M; Ingrand P; Debiais-Delpech C; Raynaud N; Chalhoub K; Guérif S
Prog Urol; 2021 Oct; 31(12):683-691. PubMed ID: 34154955
[TBL] [Abstract][Full Text] [Related]
12. Target definition in salvage postoperative radiotherapy for prostate cancer: 18F-fluorocholine PET/CT assessment of local recurrence.
El Kabbaj O; Robin P; Bourhis D; Dissaux G; Rosenfelder N; Valeri A; Fournier G; Salaun PY; Pradier O; Malhaire JP; Abgral R; Schick U
Acta Oncol; 2018 Mar; 57(3):375-381. PubMed ID: 28984165
[TBL] [Abstract][Full Text] [Related]
13. Clinical utility of (18)F-fluorocholine positron-emission tomography/computed tomography (PET/CT) in biochemical relapse of prostate cancer after radical treatment: results of a multicentre study.
Rodado-Marina S; Coronado-Poggio M; García-Vicente AM; García-Garzón JR; Alonso-Farto JC; de la Jara AC; Maldonado-Suárez A; Rodríguez-Fernández A
BJU Int; 2015 Jun; 115(6):874-83. PubMed ID: 25307619
[TBL] [Abstract][Full Text] [Related]
14. Dual-phase (18)F-fluorocholine PET/CT to detect locoregional recurrence of prostate cancer: comparison between each time point of imaging and a summation scan.
Tong AK; Zhang ZX; Zaheer S; Yan XS
Clin Imaging; 2016; 40(3):486-91. PubMed ID: 27133692
[TBL] [Abstract][Full Text] [Related]
15. Does Choline PET/CT Change the Management of Prostate Cancer Patients With Biochemical Failure?
Goldstein J; Even-Sapir E; Ben-Haim S; Saad A; Spieler B; Davidson T; Berger R; Weiss I; Appel S; Lawrence YR; Symon Z
Am J Clin Oncol; 2017 Jun; 40(3):256-259. PubMed ID: 25319322
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic performance of a streamlined
Frood R; Baren J; McDermott G; Bottomley D; Patel C; Scarsbrook A
Clin Radiol; 2018 Jul; 73(7):632-639. PubMed ID: 29716721
[TBL] [Abstract][Full Text] [Related]
17. Imaging of Prostate Cancer Using
Hodolič M
PET Clin; 2017 Apr; 12(2):173-184. PubMed ID: 28267451
[No Abstract] [Full Text] [Related]
18. Comparison of
Gauthé M; Zarca K; Aveline C; Lecouvet F; Balogova S; Cussenot O; Talbot JN; Durand-Zaleski I
BMC Med Imaging; 2020 Mar; 20(1):25. PubMed ID: 32122345
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of 18F-fluorocoline PET/CT in prostate cancer patients with biochemical recurrence: Influence of PSA kinetics and hormone therapy.
Triviño-Ibáñez EM; Puche-Sanz I; Gómez-Río M; Cózar Olmo JM; Llamas-Elvira JM; Rodríguez-Fernández A
Med Clin (Barc); 2019 Jul; 153(2):56-62. PubMed ID: 30660434
[TBL] [Abstract][Full Text] [Related]
20. Whole-body diffusion-weighted magnetic resonance imaging (WB-DW-MRI) vs choline-positron emission tomography-computed tomography (choline-PET/CT) for selecting treatments in recurrent prostate cancer.
Conde-Moreno AJ; Herrando-Parreño G; Muelas-Soria R; Ferrer-Rebolleda J; Broseta-Torres R; Cozar-Santiago MP; García-Piñón F; Ferrer-Albiach C
Clin Transl Oncol; 2017 May; 19(5):553-561. PubMed ID: 27796820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]